Click image to enlarge
-
-
Specifications
-
-
Documentation
-
References
Product Inserts
|
|
|
Datasheets
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
BAY 1000394, a novel cyclin-dependent kinase inhibitor, with potent antitumor activity in mono- and in combination treatment upon oral application.
|
|
|
|
ERK activation by GM-CSF reduces effectiveness of p38 inhibitor on inhibiting TNFalpha release.
|
|
|
|
|
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters